Patricia Cristina de Veras Souza Maia

Patricia Cristina de Veras Souza Maia

Auto-generated profile, based on publicly available information

Patricia Cristina de Veras Souza Maia

University Federal Rural of Pernambuco

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Arquivos do Instituto Biológico
Verified
Journal Article
Open access
PDF file
VSVanessa Pimentel Santos
Vanessa Pimentel Santos
PMPatrícia Maia
Patrícia Maia
NANathália de Sá Alencar
Nathália de Sá Alencar
LFLaryssa Farias
Laryssa Farias
RARosileide Andrade
Rosileide Andrade
GTGalba Maria De Campos Takaki
Galba Maria De Campos Takaki
In this study, chitin and chitosan were extracted from Litopenaeus vannamei waste using chemical and microwave methods. Shrimp waste was cleaned, dried and ground sieved to 16, 32 and 60 mesh, and the samples were depigmented, demineralized, and deproteinized. Then, the chitin was submitted to a deacetylation process by 45% NaOH solution under microwave irradiation at 600w, for intermittent 15 min or using 5 pulses of 5 minutes. The study showed that the effectiveness of the particle size of 32 mesh and 6 pulses of 5 min to deacetylation with 92% of degree and chitosan yield (52.2%). The polymer chitosan showed higher antimicrobial activity against to Staphylococcus aureus, Escherichia coli, Salmonella enterica and the yeast Candida sp., respectively. The results indicated the feasibility of the microwave radiation as an attractive method to recover chitin and chitosan from shrimp wastes.

17 April 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
PMPatricia Cristina de Veras Souza Maia
Patricia Cristina de Veras Souza Maia
Dayana Montero RodríguezDayana Montero Rodríguez
Dayana Montero Rodríguez
ASAdriana Ferreira de Souza
Adriana Ferreira de Souza
RARosileide Andrade
Rosileide Andrade
GTGalba Maria De Campos Takaki
Galba Maria De Campos Takaki
This study focused on the low-cost production of biosurfactant by Bacillus subtilis UCP 0999, using cassava wastewater (CWW) and waste frying oil (WFO) as renewable substrates. A 22 full-factorial design (FFD) was employed to investigate the effects of concentrations of agro-industrial wastes in surface tension (ST) and emulsification index (EI24). According to the results, the minimum value of ST (33.2 mN/m) and the maximum value of EI24 (95%) was obtained at central point of the FFD, using 5% CWW and 2% WFO. Statistical analyses demonstrated the significative influence of both substrates in ST and EI24. The biosurfactant showed 2.67 g/L yield and anionic and lipopeptide nature by Zeta potential and Fourier transform infrared (FT-IR) spectroscopy, respectively. In addition, promising applications of biosurfactant as biodispersant and viscosity reducing agent were demonstrated, suggesting its potential use in petroleum industry or bioremediation of hydrophobic pollutants.

1 November 2026 in Revista ft
Verified
Journal Article
Open access
LBLaysla Tamyres de Oliveira Borges
Laysla Tamyres de Oliveira Borges
POPaulo José de Andrade Lira Oliveira
Paulo José de Andrade Lira Oliveira
NSNatália Maria Valeriano da Silva
Natália Maria Valeriano da Silva
MOMaria Clara Gomes Oliveira
Maria Clara Gomes Oliveira
RTRafael Ramos Teles
Rafael Ramos Teles
MSMilena Marcia da Silva
Milena Marcia da Silva
Introduction: liquid biopsy, through the analysis of circulating tumor DNA (ctDNA), has become established in precision oncology as a tool to detect molecular residual disease and predict recurrence in solid tumors. Objective: to review recent advances in the use of ctDNA during follow-up after curative-intent treatment, highlighting clinical applications, therapeutic implications and current limitations. Methods: narrative literature review with a structured search strategy in PubMed/MEDLINE, SciELO and Google Scholar, using DeCS and MeSH descriptors combined with Boolean operators, covering 2021 to 2026; after screening of titles, abstracts and full texts, nine studies made up the final sample. Results: ctDNA detection after curative treatment identifies high-risk patients before radiological progression, with the most consistent evidence in colorectal cancer and promising results in breast cancer, non-small cell lung cancer and melanoma. Tumor-informed and tumor-agnostic approaches support risk stratification and individualized therapeutic decisions, including escalation and de-escalation of adjuvant therapy. However, analytical and clinical challenges remain, such as false-positive results caused by clonal hematopoiesis, reduced sensitivity at certain anatomical sites, lack of standardized protocols and high cost. Conclusion: ctDNA is a promising biomarker for the early detection of molecular residual disease and recurrence prediction, supporting personalized cancer care; nevertheless, its broad clinical adoption depends on further prospective validation, methodological standardization and cost reduction.